“…Inspired by the bioresponsive pancreatic system, advanced biomaterial platforms have been emerging in the form of glucose‐responsive nanocomposite hydrogels, which can be designed by incorporating glucose‐sensitive native proteins (i.e., glucose oxidase enzyme or concanavalin A) or synthetic moieties capable of responding to the presence of glucose and its derivatives (i.e., phenylboronic acid), by dynamically binding to cis‐diol motifs. [ 45,100 ] In this context, several hybrid platforms have been successfully designed with glucose‐responsive insulin delivery features. [ 45,101 ] So far, most hybrid systems are designed to rely on enzyme‐dependent glucose recognition, taking advantage of glucose oxidase conversion of an initial glucose input into two distinct stimuli outputs in the form of decreased pH (i.e., gluconic acid formation) and ROS production (i.e., hydrogen peroxide generation).…”